News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,121 Results
Type
Article (39153)
Company Profile (283)
Press Release (648685)
Section
Business (203906)
Career Advice (1996)
Deals (35374)
Drug Delivery (89)
Drug Development (80853)
Employer Resources (168)
FDA (16099)
Job Trends (14808)
News (344649)
Policy (32450)
Tag
Academia (2530)
Alliances (49189)
Alzheimer's disease (1263)
Approvals (16066)
Artificial intelligence (146)
Bankruptcy (353)
Best Places to Work (11582)
Biotechnology (200)
Breast cancer (190)
Cancer (1381)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (284)
Clinical research (64721)
Collaboration (486)
Compensation (264)
COVID-19 (2542)
C-suite (109)
Data (1396)
Diabetes (177)
Diagnostics (6171)
Earnings (84899)
Employer resources (146)
Events (110025)
Executive appointments (400)
FDA (16795)
Funding (437)
Gene therapy (197)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2635)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16353)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7864)
Lung cancer (200)
Manufacturing (207)
Medical device (13214)
Medtech (13219)
Mergers & acquisitions (19201)
Metabolic disorders (461)
Neuroscience (1587)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1709)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (122)
People (56469)
Phase I (20134)
Phase II (28501)
Phase III (21245)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5891)
Regulatory (21690)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1474)
Startups (3562)
United States (15303)
Vaccines (564)
Weight loss (182)
Date
Today (34)
Last 7 days (98)
Last 30 days (2074)
Last 365 days (35225)
2024 (35225)
2023 (40076)
2022 (51174)
2021 (55711)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37288)
Australia (6089)
California (3851)
Canada (1461)
China (314)
Colorado (173)
Connecticut (179)
Europe (79849)
Florida (539)
Georgia (136)
Illinois (387)
Indiana (227)
Maryland (638)
Massachusetts (2982)
Michigan (175)
Minnesota (294)
New Jersey (1113)
New York (1098)
North Carolina (744)
Northern California (1709)
Ohio (146)
Pennsylvania (932)
South America (1092)
Southern California (1474)
Texas (556)
Utah (108)
Washington State (401)
688,121 Results for "maxcyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MaxCyte Announces Retirement of Board Member Art Mandell
December 23, 2024
·
4 min read
Press Releases
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance
December 9, 2024
·
5 min read
Press Releases
MaxCyte to Participate in Two Upcoming Investor Conferences
October 31, 2024
·
1 min read
BioCapital
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
MaxCyte, Inc. announced Company management will participate at the William Blair 44th Annual Growth Stock Conference on Wednesday, June 5th at 2:40 pm CT.
May 29, 2024
·
1 min read
BioCapital
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
MaxCyte, Inc. announced it has entered into a strategic platform license agreement with Legend Biotech, a global leader in cell therapy.
May 22, 2024
·
7 min read
Business
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT) today announced its first quarter ended March 31, 2024 financial results and updated its 2024 guidance.
May 7, 2024
·
13 min read
Press Releases
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
·
4 min read
Press Releases
MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics
November 13, 2024
·
5 min read
Press Releases
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer
October 10, 2024
·
5 min read
Business
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT) today announced that it will release financial results for the first quarter 2024 after the U.S. market close on Tuesday, May 7th, 2024.
April 10, 2024
·
2 min read
1 of 68,813
Next
